News & Perspective

(CIDRAP News) – A second seasonal influenza vaccine made by Novartis was approved recently by the US Food and Drug Administration (FDA), and the company said some doses may reach the market this flu season.

(CIDRAP News) – In an update on H1N1 influenza activity, the World Health Organization (WHO) said today that 168 countries and territories on all continents have now had cases and that the new virus increasingly dominates the flu landscape.

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.